Purpose: Nanotechnologies turned out to be promising in the development of diagnostic and therapeutic approaches toward neurodegenerative disorders. However, only a very scant number of nanodevices until now proved to be effective on preclinical animal models. While specific tests in vivo are available to assess the potential toxicity of these nanodevices on cognitive functions, those to evaluate their biosafety in vitro on neurons are still to be improved. Patients and methods: We utilized the patch clamp technique on primary cultures of cortical neural cells isolated from neonatal rats, aiming to evaluate their electrical properties after the incubation with liposomes (mApoE-PA-LIPs), previously proved able to cross the blood brain barrier and to be effective on mouse models of Alzheimer’s disease (AD), in absence and in presence of β-amyloid peptide oligomers. Results: Data show a high degree of biocompatibility, evaluated by LDH release and MTT assay, and the lack of cellular internalization. After the incubation with mApoE-PA-LIPs neuronal membranes show an increase in the input resistance (from 724,14±76 M in untreated population to 886,06±86 M in the treated one) a reduction in the rheobase current (from 29.6±3 pA to 24.2±3 pA in untreated and treated, respectively), and an increase of the firing frequency, consistent with an ultimately increase in intrinsic excitability. Data obtained after co-incubation of mApoE-PA-LIPs with β-amyloid peptide oligomers suggested a retention of liposome efficacy. Conclusion: These data suggest the ability of liposomes to modulate neuronal electrical properties and are compatible with the previously demonstrated amelioration of cognitive functions induced by treatment of AD mice with liposomes. We conclude that this electrophysiological approach could represent a useful tool for nanomedicine to evaluate the effect of NP on intrinsic neuronal excitability

Binda, A., Panariti, A., Barbuti, A., Murano, C., Dal Magro, R., Masserini, M., et al. (2018). Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018/13, 4059-4071 [10.2147/IJN.S161563].

Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease

Binda, A;Panariti, A;MURANO, CARMEN;Dal Magro, R;Masserini, M;Re, F;Rivolta, I
2018

Abstract

Purpose: Nanotechnologies turned out to be promising in the development of diagnostic and therapeutic approaches toward neurodegenerative disorders. However, only a very scant number of nanodevices until now proved to be effective on preclinical animal models. While specific tests in vivo are available to assess the potential toxicity of these nanodevices on cognitive functions, those to evaluate their biosafety in vitro on neurons are still to be improved. Patients and methods: We utilized the patch clamp technique on primary cultures of cortical neural cells isolated from neonatal rats, aiming to evaluate their electrical properties after the incubation with liposomes (mApoE-PA-LIPs), previously proved able to cross the blood brain barrier and to be effective on mouse models of Alzheimer’s disease (AD), in absence and in presence of β-amyloid peptide oligomers. Results: Data show a high degree of biocompatibility, evaluated by LDH release and MTT assay, and the lack of cellular internalization. After the incubation with mApoE-PA-LIPs neuronal membranes show an increase in the input resistance (from 724,14±76 M in untreated population to 886,06±86 M in the treated one) a reduction in the rheobase current (from 29.6±3 pA to 24.2±3 pA in untreated and treated, respectively), and an increase of the firing frequency, consistent with an ultimately increase in intrinsic excitability. Data obtained after co-incubation of mApoE-PA-LIPs with β-amyloid peptide oligomers suggested a retention of liposome efficacy. Conclusion: These data suggest the ability of liposomes to modulate neuronal electrical properties and are compatible with the previously demonstrated amelioration of cognitive functions induced by treatment of AD mice with liposomes. We conclude that this electrophysiological approach could represent a useful tool for nanomedicine to evaluate the effect of NP on intrinsic neuronal excitability
Articolo in rivista - Articolo scientifico
neurodegenerative disorders, nanomedicine, action potential, electrophysiology, patch clamp, β-amyloid peptide
English
2018
2018/13
4059
4071
partially_open
Binda, A., Panariti, A., Barbuti, A., Murano, C., Dal Magro, R., Masserini, M., et al. (2018). Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018/13, 4059-4071 [10.2147/IJN.S161563].
File in questo prodotto:
File Dimensione Formato  
10281-198501.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 2.7 MB
Formato Adobe PDF
2.7 MB Adobe PDF Visualizza/Apri
Binda et al. Int J Nanomed 2018.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 2.55 MB
Formato Adobe PDF
2.55 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/198501
Citazioni
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 17
Social impact